Improving cancer research and treatment in Oklahoma
Official title: Mentoring Translational Cancer Research in Oklahoma
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10936135 · Data updated 2026-11-12
This study is all about improving cancer research in Oklahoma, especially for communities that are hit hard by cancer, like Native Americans, so that we can find better treatments and help more patients live healthier lives.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | August 10, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $1,072,500 |
| NIH project number | 1P30GM154635-01 |
| Project ID | NIH-10936135 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include cancer patients, particularly those from diverse communities affected by high cancer rates.
✕Less likely to help
Patients with non-cancer-related health issues may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing cancer research capabilities in Oklahoma, particularly addressing the high incidence and mortality rates of cancer in diverse communities, including Native American populations. The project aims to build on previous successes by mentoring researchers and improving core facilities that support cancer research. Through collaboration and community outreach, the initiative seeks to foster sustainable growth in cancer research, ultimately leading to better treatment options and outcomes for patients. The research will also involve securing competitive grants and publishing findings to advance knowledge in the field.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and outcomes for patients in Oklahoma.
How similar studies have gone: Previous phases of this research have shown success in advancing cancer research and securing funding, indicating a strong potential for continued progress.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Dhanasekaran, Danny N. — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Dhanasekaran, Danny N.
Related research
Other NIH-funded projects on the same topics.
-
Primary care research network in Oklahoma to boost rural patient trials
A nationwide NIH-supported effort to strengthen Oklahoma’s primary care research network so doctors can run big clinical trials and real‑world studies in rural communities.
-
N-myristoylation and DNA damage response in Alzheimer’s disease
A study to understand how a protein modification called myristoylation affects the DNA damage response in people who have Alzheimer’s-related conditions.
-
Genetically engineered mouse model to study and treat high-risk pediatric rhabdomyosarcoma
A research project aims to create mouse models that mimic high-risk pediatric rhabdomyosarcoma and test therapies that target the NOTCH1 pathway to slow or stop tumor growth.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Vascular signals from brain blood vessels influence immune-suppressing cells in glioblastoma
This grant explores how blood vessel cells in glioblastoma shape immune cells to help the tumor grow, with the aim of making immunotherapies work better for patients.
-
TFEB as a key switch to keep muscles healthy as we age
A study in aging adults and aging muscle tissues looks at whether boosting TFEB can improve how muscles maintain themselves and recover after disuse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.